OSAS-Related inflammatory mechanisms of liver injury in nonalcoholic fatty liver disease

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Paschetta, Elena ^a   Belci, Paola ^b   Alisi, Anna ^c   Liccardo, Daniela ^c   Cutrera, Renato ^c   Musso, Giovanni ^a   Nobili, Valerio ^c  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; HYPOXIA INDUCIBLE FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; UNCLASSIFIED DRUG; YKL 40 PROTEIN; ADIPOCYTOKINE; CHI3L1 PROTEIN, HUMAN; CHITINASE 3 LIKE PROTEIN 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LECTIN; TUMOR NECROSIS FACTOR;

ADIPOSE TISSUE INFLAMMATION; CHRONIC INTERMITTENT HYPOXIA; HEPATITIS; HUMAN; INFLAMMATION; LIVER INJURY; MOLECULAR PATHOLOGY; NONALCOHOLIC FATTY LIVER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SLEEP DISORDERED BREATHING; STEATOSIS; UNFOLDED PROTEIN RESPONSE; BLOOD; COMPLICATION; HYPOXIA; INSULIN RESISTANCE; NON-ALCOHOLIC FATTY LIVER DISEASE; PHYSIOLOGY;

ADIPOKINES; CHITINASE-3-LIKE PROTEIN 1; HUMANS; HYPOXIA; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INFLAMMATION; INSULIN RESISTANCE; LECTINS; NF-KAPPA B; NON-ALCOHOLIC FATTY LIVER DISEASE; SLEEP APNEA, OBSTRUCTIVE; TUMOR NECROSIS FACTOR-ALPHA; UNFOLDED PROTEIN RESPONSE;

EID: 84926389798     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/815721     Document Type: Review

References (103)

1. T. Young, M. Palta, J. Dempsey, J. Skatrud, S. Weber, and S. Badr, "The occurrence of sleep-disordered breathing among middleaged adults", The New England Journal of Medicine, vol. 328, no. 17, pp. 1230-1235, 1993.
2. A. N. Vgontzas, T. L. Tan, E. O. Bixler, L. F. Martin, D. Shubert, and A. Kales, "Sleep apnea and sleep disruption in obese patients", Archives of Internal Medicine, vol. 154, no. 15, pp. 1705-1711, 1994.
3. S. D. West, D. J. Nicoll, and J. R. Stradling, "Prevalence of obstructive sleep apnoea in men with type 2 diabetes", Thorax, vol. 61, no. 11, pp. 945-950, 2006.
4. S. R. Coughlin, L. Mawdsley, J. A. Mugarza, P. M. A. Calverley, and J. P. H. Wilding, "Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome", European Heart Journal, vol. 25, no. 9, pp. 735-741, 2004.
5. J. M. Marin, S. J. Carrizo, E. Vicente, and A. G. N. Agusti, "Longterm cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study", Lancet, vol. 365, no. 9464, pp. 1046-1053, 2005.
6. N. Botros, J. Concato, V. Mohsenin, B. Selim, K. Doctor, and H. K. Yaggi, "Obstructive sleep apnea as a risk factor for type 2 diabetes", The American Journal of Medicine, vol. 122, no. 12, pp. 1122-1127, 2009.
7. T. U. Ciftci, O. Kokturk, N. Bukan, and A. Bilgihan, "The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome", Cytokine, vol. 28, no. 2, pp. 87-91, 2004.
8. S. Ryan, C. T. Taylor, and W. T. McNicholas, "Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome", Circulation, vol. 112, no. 17, pp. 2660-2667, 2005.
9. K. Christou, N. Markoulis, A. N. Moulas, C. Pastaka, and K. I. Gourgoulianis, "Reactive oxygen metabolites (ROMs) as an index of oxidative stress in obstructive sleep apnea patients", Sleep and Breathing, vol. 7, no. 3, pp. 105-110, 2003.
10. G. Musso, C. Olivetti, M. Cassader, and R. Gambino, "Obstructive sleep apnea-hypopnea syndrome and nonalcoholic fatty liver disease: emerging evidence and mechanisms", Seminars in Liver Disease, vol. 32, no. 1, pp. 49-64, 2012.
11. A.-C. Piguet, D. Stroka, A. Zimmermann, and J.-F. Dufour, "Hypoxia aggravates non-alcoholic steatohepatitis in mice lacking hepatocellular PTEN", Clinical Science, vol. 118, no. 6, pp. 401-410, 2010.
12. N. Chalasani, Z. Younossi, J. E. Lavine et al., "The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association", Hepatology, vol. 55, no. 6, pp. 2005-2023, 2012.
13. G. Musso, R. Gambino, M. Cassader, and G. Pagano, "Metaanalysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity", Annals of Medicine, vol. 43, no. 8, pp. 617-649, 2011.
14. G. Musso, R. Gambino, J. H. Tabibian et al., "Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic reviewandmeta-analysis", PLoS Medicine, vol. 11, no. 7, Article ID e1001680, 2014.
15. L. Lavie, "Obstructive sleep apnoea syndrome-an oxidative stress disorder", Sleep Medicine Reviews, vol. 7, no. 1, pp. 35-51, 2003.
16. V. Savransky, A. Nanayakkara, A. Vivero et al., "Chronic intermittent hypoxia predisposes to liver injury", Hepatology, vol. 45, no. 4, pp. 1007-1013, 2007.
17. V. Savransky, S. Bevans, A. Nanayakkara et al., "Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver", The American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 293, no. 4, pp. G871-G877, 2007.
18. B. D. Hegarty, A. Bobard, I. Hainault, P. Ferré, P. Bossard, and F. Foufelle, "Distinct roles of insulin and liver X receptor in the induction and cleavage of sterol regulatory element-binding protein-1c", Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 3, pp. 791-796, 2005.
19. J. L. Goldstein, R. A. DeBose-Boyd, and M. S. Brown, "Protein sensors for membrane sterols", Cell, vol. 124, no. 1, pp. 35-46, 2006.
20. M. H. Ahmed and C. D. Byrne, "Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD)", Drug Discovery Today, vol. 12, no. 17-18, pp. 740-747, 2007.
21. G. Musso, S. Bo, M. Cassader, F. de Michieli, and R. Gambino, "Impact of sterol regulatory element-binding factor-1c polymorphism on incidence of nonalcoholic fatty liver disease and on the severity of liver disease and of glucose and lipid dysmetabolism", The American Journal of Clinical Nutrition, vol. 98, no. 4, pp. 895-906, 2013.
22. F. Foufelle and P. Ferré, "Regulation of carbohydrate metabolism by insulin: role of transcription factor SREBP-1c in the hepatic transcriptional effects of the hormone", Journal de la Societe de Biologie, vol. 195, no. 3, pp. 243-248, 2001.
23. P. Ferré, "The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity", Diabetes, vol. 53, no. 1, pp. S43-S50, 2004.
24. F. J. Gonzalez, "Recent update on the PPARγ-null mouse", Biochimie, vol. 79, no. 2-3, pp. 139-144, 1997.
25. W. V. Berghe, L. Vermeulen, P. Delerive, K. de Bosscher, B. Staels, and G. Haegeman, "A paradigm for gene regulation: Inflammation, NF-κB and PPAR", Advances in Experimental Medicine and Biology, vol. 544, pp. 181-196, 2003.
26. G. Musso, M. Cassader, C. Olivetti, F. Rosina, G. Carbone, and R. Gambino, "Association of obstructive sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review and meta-analysis", Obesity Reviews, vol. 14, no. 5, pp. 417-431, 2013.
27. V. Nobili, R. Cutrera, D. Liccardo et al., "Obstructive sleepapnea syndrome affects liver histology and inflammatory cell activation in pediatric nonalcoholic fatty liver disease, regardless of obesity/insulin resistance", American Journal of Respiratory and Critical Care Medicine, vol. 189, no. 1, pp. 66-76, 2014.
28. S. S. Sundaram, R. J. Sokol, K. E. Capocelli et al., "Obstructive sleep apnea and hypoxemia are associated with advanced liver histology in pediatric nonalcoholic fatty liver disease", The Journal of Pediatrics, vol. 164, no. 4, pp. 699.e1-706.e1, 2014.
29. C. A. Rivera, P. Adegboyega, N. van Rooijen, A. Tagalicud, M. Allman, and M. Wallace, "Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of nonalcoholic steatohepatitis", Journal of Hepatology, vol. 47, no. 4, pp. 571-579, 2007.
30. A. Qu, M. Taylor, X. Xue et al., "Hypoxia-inducible transcription factor 2α promotes steatohepatitis through augmenting lipid accumulation, inflammation, and fibrosis", Hepatology, vol. 54, no. 2, pp. 472-483, 2011.
31. B. L. Copple, S. Bai, L. D. Burgoon, and J.-O. Moon, "Hypoxiainducible factor-1α regulates the expression of genes in hypoxic hepatic stellate cells important for collagen deposition and angiogenesis", Liver International, vol. 31, no. 2, pp. 230-244, 2011.
32. T. D. Gilmore and M. Herscovitch, "Inhibitors of NF-κB signaling:785 and counting", Oncogene, vol. 25, no. 51, pp. 6887-6899, 2006.
33. M. S. Hayden and S. Ghosh, "Signaling to NF-kappaB", Genes & Development, vol. 18, no. 18, pp. 2195-2224, 2004.
34. J. C. M. Lam, J. C. W. Mak, and M. S. M. Ip, "Obesity, obstructive sleep apnoea and metabolic syndrome", Respirology, vol. 17, no. 2, pp. 223-236, 2012.
35. S. M. Robinson and D. A. Mann, "Role of nuclear factor kappaB in liver health and disease", Clinical Science, vol. 118, no. 12, pp. 691-705, 2010.
36. T. Luedde and R. F. Schwabe, "NF-κB in the liver-linking injury, fibrosis and hepatocellular carcinoma", Nature Reviews Gastroenterology and Hepatology, vol. 8, no. 2, pp. 108-118, 2011.
37. A. K. Htoo, H. Greenberg, S. Tongia et al., "Activation of nuclear factor kappa B in obstructive sleep apnea: a pathway leading to systemic inflammation", Sleep and Breathing, vol. 10, no. 1, pp. 43-50, 2006.
38. A. Melvin, S. Mudie, and S. Rocha, "Mechanism of hypoxiainduced NFκB", Cell Cycle, vol. 10, no. 6, pp. 879-882, 2011.
39. J. Li, R. Fan, S. Zhao et al., "Reactive oxygen species released from hypoxic hepatocytes regulates MMP-2 expression in hepatic stellate cells", International Journal of Molecular Sciences, vol. 12, no. 4, pp. 2434-2447, 2011.
40. L. Imeri and M. R. Opp, "How (and why) the immune system makes us sleep", Nature Reviews Neuroscience, vol. 10, no. 3, pp. 199-210, 2009.
41. C. L. Gentile, M. Frye, and M. J. Pagliassotti, "Endoplasmic reticulum stress and the unfolded protein response in nonalcoholic fatty liver disease", Antioxidants & Redox Signaling, vol. 15, no. 2, pp. 505-521, 2011.
42. P. Puri, F. Mirshahi, O. Cheung et al., "Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease", Gastroenterology, vol. 134, no. 2, pp. 568-576, 2008.
43. P. Walter and D. Ron, "The unfolded protein response: from stress pathway to homeostatic regulation", Science, vol. 334, no. 6059, pp. 1081-1086, 2011.
44. J. A. Diehl, S. Y. Fuchs, and C. Koumenis, "The cell biology of the unfolded protein response", Gastroenterology, vol. 141, no. 1, pp. 38-41, 2011.
45. C. Hetz, F. Martinon, D. Rodriguez, and L. H. Glimcher, "The unfolded protein response: integrating stress signals through the stress sensor IRE1 α", Physiological Reviews, vol. 91, no. 4, pp. 1219-1243, 2011.
46. T. van den Beucken, M. G. Magagnin, B. Jutten et al., "Translational control is a major contributor to hypoxia induced gene expression", Radiotherapy and Oncology, vol. 99, no. 3, pp. 379-384, 2011.
47. H.-M. Ni, X. Chen, Y.-H. Shi et al., "Genetic delineation of the pathways mediated by bid and JNK in tumor necrosis factoralphainduced liver injury in adult and embryonic mice", The Journal of Biological Chemistry, vol. 284, no. 7, pp. 4373-4382, 2009.
48. H. Sugimoto, K. Okada, J. Shoda et al., "Deletion of nuclear factor-E2-related factor-2 leads to rapid onset and progression of nutritional steatohepatitis in mice", American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 298, no. 2, pp. G283-G294, 2010.
49. L. Zeng, M. Lu, K. Mori et al., "ATF6 modulates SREBP2-mediated lipogenesis", The EMBO Journal, vol. 23, no. 4, pp. 950-958, 2004.
50. G. Musso, R. Gambino, M. Durazzo et al., "Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease", Hepatology, vol. 42, no. 5, pp. 1175-1183, 2005.
51. M. Pasarica, O. R. Sereda, L. M. Redman et al., "Reduced adipose tissue oxygenation in human obesity evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response", Diabetes, vol. 58, no. 3, pp. 718-725, 2009.
52. B. Wang, I. S. Wood, and P. Trayhurn, "Dysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytes", Pflügers Archiv, vol. 455, no. 3, pp. 479-492, 2007.
53. J. Ye, Z. Gao, J. Yin, and Q. He, "Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice", American Journal of Physiology-Endocrinology and Metabolism, vol. 293, no. 4, pp. E1118-E1128, 2007.
54. J. Yin, Z. Gao, Q. He, D. Zhou, Z. Guo, and J. Ye, "Role of hypoxia in obesity-induced disorders of glucose and lipid metabolism in adipose tissue", The American Journal of Physiology-Endocrinology and Metabolism, vol. 296, no. 2, pp. E333-E342, 2009.
55. S. Ryan, C. T. Taylor, and W. T. McNicholas, "Predictors of elevated nuclear factor-αB-dependent genes in obstructive sleep apnea syndrome", American Journal of Respiratory and Critical Care Medicine, vol. 174, no. 7, pp. 824-830, 2006.
56. Z. Li, M. J. Soloski, and A. M. Diehl, "Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease", Hepatology, vol. 42, no. 4, pp. 880-885, 2005.
57. P. C. Heinrich, J. V. Castell, and T. Andus, "Interleukin-6 and the acute phase response", Biochemical Journal, vol. 265, no. 3, pp. 621-636, 1990.
58. A. N. Vgontzas, D. A. Papanicolaou, E. O. Bixler et al., "Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia", The Journal of Clinical Endocrinology & Metabolism, vol. 85, no. 3, pp. 1151-1158, 2000.
59. P. Entzian, K. Linnemann, M. Schlaak, and P. Zabel, "Obstructive sleep apnea syndrome and circadian rhythms of hormones and cytokines", American Journal of Respiratory and Critical Care Medicine, vol. 153, no. 3, pp. 1080-1086, 1996.
60. B. Nath, I. Levin, T. Csak et al., "Hepatocyte-specific hypoxiainducible factor-1α is a determinant of lipid accumulation and liver injury in alcohol-induced steatosis in mice", Hepatology, vol. 53, no. 5, pp. 1526-1537, 2011.
61. J. Li, V. Savransky, A. Nanayakkara, P. L. Smith, C. P. O'Donnell, and V. Y. Polotsky, "Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia", Journal of Applied Physiology, vol. 102, no. 2, pp. 557-563, 2007.
62. E. B. Rankin, J. Rha, M. A. Selak et al., "Hypoxia-inducible factor 2 regulates hepatic lipid metabolism", Molecular and Cellular Biology, vol. 29, no. 16, pp. 4527-4538, 2009.
63. A. Marín-Hernández, J. C. Gallardo-Pérez, S. J. Ralph, S. Rodríguez-Enríquez, and R. Moreno-Sánchez, "HIF-1α modulates energy metabolism in cancer cells by inducing overexpression of specific glycolytic isoforms", Mini-Reviews in Medicinal Chemistry, vol. 9, no. 9, pp. 1084-1101, 2009.
64. J.-O. K. Moon, T. P. Welch, F. J. Gonzalez, and B. L. Copple, "Reduced liver fibrosis in hypoxia-inducible factor-1α-deficient mice", American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 296, no. 3, pp. G582-G592, 2009.
65. B. L. Copple, S. Bai, and J.-O. Moon, "Hypoxia-inducible factordependent production of profibrotic mediators by hypoxic Kupffer cells", Hepatology Research, vol. 40, no. 5, pp. 530-539, 2010.
66. L. F. Drager, J. Li, M.-K. Shin et al., "Intermittent hypoxia inhibits clearance of triglyceride-rich lipoproteins and inactivates adipose lipoprotein lipase in a mouse model of sleep apnoea", European Heart Journal, vol. 33, no. 6, pp. 783-790, 2012.
67. B. Kucejova, N. E. Sunny, A. D. Nguyen et al., "Uncoupling hypoxia signaling from oxygen sensing in the liver results in hypoketotic hypoglycemic death", Oncogene, vol. 30, no. 18, pp. 2147-2160, 2011.
68. E. Tasali and M. S. M. Ip, "Obstructive sleep apnea and metabolic syndrome: alterations in glucose metabolism and inflammation", Proceedings of the American Thoracic Society, vol. 5, no. 2, pp. 207-217, 2008.
69. K. Minoguchi, T. Yokoe, A. Tanaka et al., "Association between lipid peroxidation and inflammation in obstructive sleep apnoea", European Respiratory Journal, vol. 28, no. 2, pp. 378-385, 2006.
70. K. Z. Boudjeltia, A. van Meerhaeghe, S. Doumit et al., "Sleep apnoea-hypopnoea index is an independent predictor of highsensitivity C-reactive protein elevation", Respiration, vol. 73, no. 2, pp. 243-246, 2006.
71. F. Kapsimalis, G. Varouchakis, A. Manousaki et al., "Association of sleep apnea severity and obesity with insulin resistance, C-reactive protein, and leptin levels in male patients with obstructive sleep apnea", Lung, vol. 186, no. 4, pp. 209-217, 2008.
72. S. Savvidou, P. Hytiroglou, H. Orfanou-Koumerkeridou, A. Panderis, P. Frantzoulis, and J. Goulis, "Low serumadiponectin levels are predictive of advanced hepatic fibrosis in patients with NAFLD", Journal of Clinical Gastroenterology, vol. 43, no. 8, pp. 765-772, 2009.
73. N. Hosogai, A. Fukuhara, K. Oshima et al., "Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation", Diabetes, vol. 56, no. 4, pp. 901-911, 2007.
74. M. Fasshauer, S. Kralisch, M. Klier et al., "Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes", Biochemical and Biophysical Research Communications, vol. 301, no. 4, pp. 1045-1050, 2003.
75. J. Feng, B.-Y. Chen, L.-Y. Cui et al., "Inflammation status of rabbit carotid artery model endothelium during intermittent hypoxia exposure and its relationship with leptin", Sleep and Breathing, vol. 13, no. 3, pp. 277-283, 2009.
76. U. Meißner, C. Hänisch, I. Östreicher et al., "Differential regulation of leptin synthesis in rats during short-term hypoxia and short-term carbon monoxide inhalation", Endocrinology, vol. 146, no. 1, pp. 215-220, 2005.
77. F. Tokuda, Y. Sando, H. Matsui, H. Koike, and T. Yokoyama, "Serum levels of adipocytokines, adiponectin and leptin, in patients with obstructive sleep apnea syndrome", Internal Medicine, vol. 47, no. 21, pp. 1843-1849, 2008.
78. M. L. Coleman and P. J. Ratcliffe, "Oxygen sensing and hypoxiainduced responses", Essays in Biochemistry, vol. 43, pp. 1-15, 2007.
79. 2-regulated prolyl hydroxylation", Science, vol. 292, no. 5516, pp. 468-472, 2001.
80. Y. Benita, H. Kikuchi, A. D. Smith, M. Q. Zhang, D. C. Chung, and R. J. Xavier, "An integrative genomics approach identifies hypoxia inducible Factor-1 (HIF-1)-target genes that form the core response to hypoxia", Nucleic Acids Research, vol. 37, no. 14, pp. 4587-4602, 2009.
81. J. Yang, I. Ledaki, H. Turley et al., "Role of hypoxia-inducible factors in epigenetic regulation via histone demethylases", Annals of the New York Academy of Sciences, vol. 1177, pp. 185-197, 2009.
82. G. Musso, R. Gambino, and M. Cassader, "Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD)", Progress in Lipid Research, vol. 48, no. 1, pp. 1-26, 2009.
83. J. S. Johansen, "Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer", Danish Medical Bulletin, vol. 53, no. 2, pp. 172-209, 2006.
84. X. Wang and G.-H. Xing, "Serum YKL-40 concentrations are elevated and correlated with disease severity in patients with obstructive sleep apnea syndrome", Scandinavian Journal of Clinical & Laboratory Investigation, vol. 74, no. 1, pp. 74-78, 2014.
85. N. J. Sarma, V. Tiriveedhi, V. Subramanian et al., "Hepatitis C virus mediated changes in miRNA-449a modulates inflammatory biomarker YKL40 through components of the NOTCH signaling pathway", PLoS ONE, vol. 7, no. 11, Article ID e50826, 2012.
86. J. S. Johanshn, S. Møller, P. A. Price et al., "Plasma YKL-40: a new potential marker of fibrosis in patients with alcoholic cirrhosis?" Scandinavian Journal of Gastroenterology, vol. 32, no. 6, pp. 582-590, 1997.
87. L. L. Schiavon, J. L. Narciso-Schiavon, R. J. Carvalho Filho et al., "Serum levels of YKL-40 and hyaluronic acid as noninvasive markers of liver fibrosis in haemodialysis patients with chronic hepatitis C virus infection", Journal of Viral Hepatitis, vol. 15, no. 9, pp. 666-674, 2008.
88. J. S. Johansen, P. Christoffersen, S. Møller et al., "Serum YKL-40 is increased in patients with hepatic fibrosis", Journal of Hepatology, vol. 32, no. 6, pp. 911-920, 2000.
89. R. Malik, M. Chang, K. Bhaskar et al., "The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease", Journal of Gastroenterology and Hepatology, vol. 24, no. 4, pp. 564-568, 2009.
90. D. M. Lebensztejn, A. Wierzbicka, P. Socha et al., "Cytokeratin-18 and hyaluronic acid levels predict liver fibrosis in children with non-alcoholic fatty liver disease", Acta Biochimica Polonica, vol. 58, no. 4, pp. 563-566, 2011.
91. S. Makino, H. Handa, K. Suzukawa et al., "Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance", Clinical Endocrinology, vol. 64, no. 1, pp. 12-19, 2006.
92. K. M. Oltmanns, H. Gehring, S. Rudolf et al., "Hypoxia causes glucose intolerance in humans", The American Journal of Respiratory and Critical Care Medicine, vol. 169, no. 11, pp. 1231-1237, 2004.
93. E. Lindberg, J. Theorell-Haglöw, M. Svensson, T. Gislason, C. Berne, and C. Janson, "Sleep apnea and glucose metabolism: a long-term follow-up in a community-based sample", Chest, vol. 142, no. 4, pp. 935-942, 2012.
94. J. Keijer and E. M. van Schothorst, "Adipose tissue failure and mitochondria as a possible target for improvement by bioactive food components", Current Opinion in Lipidology, vol. 19, no. 1, pp. 4-10, 2008.
95. K. D. Bruce, F. R. Cagampang, M. Argenton et al., "Maternal high-fat feeding primes steatohepatitis in adult mice offspring, involving mitochondrial dysfunction and altered lipogenesis gene expression", Hepatology, vol. 50, no. 6, pp. 1796-1808, 2009.
96. C. L. Gentile and M. J. Pagliassotti, "The role of fatty acids in the development and progression of nonalcoholic fatty liver disease", Journal of Nutritional Biochemistry, vol. 19, no. 9, pp. 567-576, 2008.
97. C. Regazzetti, P. Peraldi, T. Grémeaux et al., "Hypoxia decreases insulin signaling pathways in adipocytes", Diabetes, vol. 58, no. 1, pp. 95-103, 2009.
98. I. S. Wood, B. Wang, S. Lorente-Cebrián, and P. Trayhurn, "Hypoxia increases expression of selective facilitative glucose transporters (GLUT) and 2-deoxy-d-glucose uptake in human adipocytes", Biochemical and Biophysical Research Communications, vol. 361, no. 2, pp. 468-473, 2007.
99. B. Wang, I. S. Wood, and P. Trayhurn, "Hypoxia induces leptin gene expression and secretion in human preadipocytes: differential effects of hypoxia on adipokine expression by preadipocytes", Journal of Endocrinology, vol. 198, no. 1, pp. 127-134, 2008.
100. F. Tanné, F. Gagnadoux, O. Chazouillères et al., "Chronic liver injury during obstructive sleep apnea", Hepatology, vol. 41, no. 6, pp. 1290-1296, 2005.
101. K. J. Woodcroft and R. F. Novak, "Insulin effects on CYP2E1, 2B, 3A, and 4A expression in primary cultured rat hepatocytes", Chemico-Biological Interactions, vol. 107, no. 1-2, pp. 75-91, 1997.
102. M. D. Weltman, G. C. Farrell, P. Hall, M. Ingelman-Sundberg, and C. Liddle, "Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis", Hepatology, vol. 27, no. 1, pp. 128-133, 1998.
103. J. M. Schattenberg, Y. Wang, R. Singh, R. M. Rigoli, and M. J. Czaja, "Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling", The Journal of Biological Chemistry, vol. 280, no. 11, pp. 9887-9894, 2008.